• Fiscal Year end for Protalix BioTherapeutics, Inc falls in the month of December .

    All items in Millions except EPS data.

    12/31/23 12/31/22 12/31/21 12/31/20 12/31/19
    Sales 65 48 38 63 55
    Cost Of Goods 23 20 16 11 11
    Gross Profit 43 28 22 52 44
    Selling & Adminstrative & Depr. & Amort Expenses 32 41 42 49 55
    Income After Depreciation & Amortization 10 -13 -20 3 -11
    Non-Operating Income -2 -1 -7 -9 -8
    Interest Expense 0 0 0 0 0
    Pretax Income 9 -14 -28 -7 -18
    Income Taxes 0 1 0 0 0
    Minority Interest 0 0 0 0 0
    Investment Gains/Losses 0 0 0 0 0
    Other Income/Charges 0 0 0 0 0
    Income From Cont. Operations 8 -15 -28 -7 -18
    Extras & Discontinued Operations 0 0 0 0 0
    Net Income (GAAP) 8 -15 -28 -7 -18
    Depreciation Footnote 12/31/23 12/31/22 12/31/21 12/31/20 12/31/19
    Income Before Depreciation & Amortization 12 -12 -17 7 -6
    Depreciation & Amortization (Cash Flow) 1 1 4 5 5
    Income After Depreciation & Amortization 10 -13 -20 3 -11
    Earnings Per Share Data 12/31/23 12/31/22 12/31/21 12/31/20 12/31/19
    Average Shares 82.42 48.47 44.14 29.15 14.84
    Diluted EPS Before Non-Recurring Items 0.09 -0.31 -0.62 -0.22 -1.23
    Diluted Net EPS (GAAP) 0.09 -0.31 -0.62 -0.22 -1.23

    Fiscal Year end for Protalix BioTherapeutics, Inc falls in the month of December .

    All items in Millions except EPS data.

    3/31/24 12/31/23 9/30/23 6/30/23 3/31/23
    Sales 3.75 10.49 10.35 35.08 9.59
    Cost Of Goods 2.60 8.86 4.89 6.15 3.09
    Gross Profit 1.15 1.63 5.45 28.93 6.50
    SG&A, R&D, and Dept/Amort Expenses 6.01 7.24 7.34 8.51 8.97
    Income After SG&A, R&D, and Dept/Amort Expenses -4.86 -5.61 -1.89 20.42 -2.47
    Non-Operating Income 0.12 -0.81 0.17 -0.77 -0.48
    Interest Expense 0.00 0.00 0.00 0.00 0.00
    Pretax Income -4.73 -6.43 -1.72 19.65 -2.94
    Income Taxes -0.14 -0.38 0.13 0.31 0.20
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Investment Gains/Losses 0.00 0.00 0.00 0.00 0.00
    Other Income/Charges 0.00 0.00 0.00 0.00 0.00
    Income From Cont. Operations -4.60 -6.04 -1.85 19.34 -3.13
    Extras & Discontinued Operations 0.00 0.00 0.00 0.00 0.00
    Income (GAAP) -4.60 -6.04 -1.85 19.34 -3.13
    Earnings Per Share Data 3/31/24 12/31/23 9/30/23 6/30/23 3/31/23
    Average Shares 73.04 82.42 83.78 83.20 57.48
    Diluted EPS Before Non-Recurring Items -0.06 -0.07 -0.04 0.21 -0.05
    Diluted Net EPS (GAAP) -0.06 -0.03 -0.04 0.21 -0.05